#166 — The Plague Years
Episode Stats
Words per Minute
166.70941
Summary
Matt McCarthy is an infectious disease doctor and professor of medicine at Cornell, where he also serves on the Ethics Committee. His writing has appeared in the New England Journal of Medicine, Sports Illustrated, Slate, and other journals; he s the author of several books, including Superbugs: The Race to Stop an Epidemic. And that s what we talk about today: the problem that many of the drugs we use to treat infectious disease are now failing, and will always be failing. We re in a perpetual arms race against evolution, and the emergence of new bugs that our immune systems have never seen. And this, quite amazingly, is a problem that is receiving very little attention, and yet it s on the short list of things that could utterly change the character of human life very much for the worse. As we will discuss, infectious diseases have been trying to sound the alarm about this for a while. So now, without further delay, I bring you Matt McCarthy, who has written a book about this topic I ve been worrying about for a long time. And, well, I m glad that he s been worried about this a while because not enough people have been thinking about it. And, you know, thanks for coming on the podcast. This is made possible entirely through the support of our subscribers, who consider what we re doing here, by becoming a supporter of our podcast. Please consider becoming a subscriber. You re gonna get a lot more than just a good time listening to the Making Sense Podcast. Thanks for listening. Sam Harris, no housekeeping today. To find a list of our sponsorships and more, go to anchor.fm/Making Sense Podcasts. And if you re looking for a good podcast, check out our ad-free version of the podcast, I ve got a good one on my podcast, you ll get a discount code, too good to recommend it, too get it there, too say so, too check it out there, I got it on Insta: and I got that too says it out on Instafeed and I also got it, it s great, too says that I got the best of it, so you get it, right here, so I say it out, I mean it, I really do it, and I love it, good thing, you rock it, you re not only that, I say that, right so it s really good, right, and all that kind of thing, etc.
Transcript
00:00:10.880
Just a note to say that if you're hearing this, you are not currently on our subscriber
00:00:14.680
feed and will only be hearing the first part of this conversation.
00:00:18.420
In order to access full episodes of the Making Sense Podcast, you'll need to subscribe at
00:00:24.060
There you'll find our private RSS feed to add to your favorite podcatcher, along with
00:00:30.620
We don't run ads on the podcast, and therefore it's made possible entirely through the support
00:00:35.900
So if you enjoy what we're doing here, please consider becoming one.
00:00:58.360
Matt is an infectious disease doctor and a professor of medicine at Cornell, where he
00:01:07.200
His writing has appeared in the New England Journal of Medicine, Sports Illustrated, Slate,
00:01:16.440
And his latest is Superbugs, The Race to Stop an Epidemic.
00:01:24.340
The problem that many of the drugs we use to treat infectious disease are now failing,
00:01:32.560
We're in a perpetual arms race against evolution and the emergence of new bugs that our immune
00:01:41.820
And this, quite amazingly, is a problem that is receiving very little attention, and yet
00:01:48.920
it's on the short list of things that could utterly transform the character of human life.
00:01:56.800
It's also on the short list of problems for which the market appears to offer no solution,
00:02:02.780
So now, without further delay, I bring you Matt McCarthy.
00:02:18.780
So, you have written a book that could be terrifying.
00:02:22.600
You try to be as hopeful as you can be throughout.
00:02:30.560
I mean, this could be my own germ phobia creeping in here, but you have written a book, Super
00:02:38.540
And this is a topic I've been worrying about for a long time.
00:02:42.100
And I think ever since that, the first Ebola scare and some of the books that followed,
00:02:49.640
and now we're talking, well, it must have been 1999 or thereabouts, maybe earlier, when
00:02:55.360
I remember Lori Garrett wrote a big book about the prospect of emerging pandemics.
00:03:00.560
Before we jump into the topic, tell us how you got into infectious disease and just what
00:03:08.360
Yeah, well, I'm glad that you've been worrying about this for a while because not enough
00:03:14.560
And I think the first thing is useful to define the term.
00:03:18.020
Some people say that drug-resistant bacteria are superbugs, but I take a much broader look
00:03:22.880
at it and say that what we're really talking about are drug-resistant fungi and parasites
00:03:28.080
and viruses and all kinds of living things that can come and attack us.
00:03:32.140
And, you know, writing this book, I wasn't trying to freak people out, but I think that
00:03:35.780
has been sort of the fallout is that people read this and go, oh, man, this is a big deal.
00:03:41.280
And those of us in infectious diseases have been trying to sound the alarm about this for
00:03:47.120
You know, the World Health Organization just came out and said that superbugs are going
00:03:50.760
to be a bigger killer than heart disease and cancer by 2050.
00:03:54.680
And so, you know, how I got into this, it wasn't something that I had always dreamed
00:04:01.180
I was a first-year medical student at Harvard in 2003, and I heard a lecture by a young and
00:04:07.400
charismatic infectious disease doctor named Paul Farmer.
00:04:11.380
And he, you know, he has traveled to Haiti and all over the world bringing drugs to people
00:04:17.040
who couldn't afford them, bringing antibiotics and HIV medicines and tuberculosis medicines
00:04:28.620
And six months later, I found myself in Western Africa hunting for the Ebola virus and trying
00:04:38.980
And so that, you know, sort of launched me in this career of trying to find what's going
00:04:43.560
to be the next big pandemic, what's going to be the thing that gets to us, and how do
00:04:47.880
we attack that, and how do we come up with treatments to stave off the next big thing?
00:04:53.760
I mean, one problem is that many of us have forgotten, or we never knew, in fact, how scary
00:05:00.080
it was to live in a world where infectious diseases were ascendant.
00:05:05.400
We have forgotten what it's like for people to routinely die from tetanus and other wound
00:05:12.220
infections, or, you know, the whole generations of people were moving to warmer climates, you
00:05:18.360
know, however, ineffectually to try to mitigate their tuberculosis and, you know, which would
00:05:23.640
And we just, we lived in a world, you know, for the longest time, forever, where there was
00:05:30.040
just simply no guarantee or even promise that infections could be reliably treated.
00:05:38.480
And then we had this fundamental breakthrough in what you detail in your book.
00:05:43.820
I mean, penicillin was the first, you know, widely available antibiotic, and it really
00:05:49.860
ushered in a golden age when you could cure, you could expect to cure, you know, all of these
00:05:58.620
And we seem to have taken it for granted up to the point where now we have fallen out of
00:06:09.040
I mean, this is the thing that most people don't realize is the luxury we have of antibiotics.
00:06:14.420
As you said, penicillin ushered in the golden era of the 1950s, where every month or two,
00:06:20.460
we were pumping out a new life-saving drug, and the life expectancy ballooned because of
00:06:28.060
And then what happened was a number of prominent scientists, Nobel laureates, came out and said,
00:06:33.160
you know, we got this infectious disease thing kicked.
00:06:35.880
It's time to move on to more pressing matters like heart disease and cancer.
00:06:40.400
And the pharmaceutical industry responded and started making chemotherapy drugs and blood
00:06:46.000
thinners and all of these lucrative things just as the superbugs were starting to mutate
00:06:51.360
and to evolve and to become resistant to our treatments.
00:06:54.360
And so now we're finding that as we're finally paying attention to this issue, we're behind
00:07:00.620
the eight ball in a sense because we're playing catch up.
00:07:03.940
The drugs aren't working as well as they used to.
00:07:06.880
And we're scrambling to find the next generation of life-saving drugs.
00:07:11.980
And, you know, I'm reminded of this every single day when I walk into the hospital.
00:07:15.460
The first place I go is the emergency room, and I meet the patients who have these drug-resistant
00:07:22.100
And that's actually what led me to write this book is that, you know, people have talked
00:07:27.100
They've talked about the policy, about the science behind it, all of the stuff sort of
00:07:33.520
But what I was interested in were the patient stories and the lives that are completely derailed
00:07:38.660
And the fact that the pharmaceutical industry is losing interest in making new antibiotics
00:07:44.460
is devastating for tens of thousands of people.
00:07:48.940
And so, you know, I'm trying to raise awareness, but also say, here's how we got in this mess,
00:07:56.160
So let's talk about, we'll talk about the ways in which the business model of the pharmaceutical
00:08:01.960
industry is not helping us here, and the market is not helping us here.
00:08:06.980
But before we get there, let's just talk about the basic science.
00:08:11.120
What we have is, it really could have been foreseen based on evolutionary principles.
00:08:17.280
I mean, this isn't surprising that we have bugs that can mutate and become resistant to
00:08:28.760
And again, the reminders of this happening are everywhere.
00:08:33.280
Yesterday, the front page of the Sunday New York Times had a story on urinary tract infections
00:08:41.120
showing antibiotic resistance to a surprising degree.
00:08:45.920
I mean, something like 30% are resistant to most antibiotics at this point.
00:08:52.900
But it's not just a matter of bugs evolving and getting around our antibiotics.
00:09:02.060
It's also just the fact that there are so-called superbugs everywhere as yet unencountered by us
00:09:09.900
because there are bacteria in the soil and elsewhere which our immune system hasn't devised
00:09:18.080
any response to and our drugs can't anticipate.
00:09:22.600
And so we will be, you know, whether they mutate or not, we are very likely to encounter
00:09:30.940
And one of the big problems we have is how doctors and scientists talk about these superbugs.
00:09:36.640
You mentioned that front page Science Times article.
00:09:39.240
I know the guy who wrote that piece because he's interviewed me before.
00:09:43.680
And, you know, one of the quotes from that article is that this level of antibiotic resistance
00:09:50.520
And I read that and I thought, shocking to who?
00:09:53.300
Because doctors know this and scientists know this.
00:09:56.480
But if this is shocking to the lay public, that's because we haven't done a good enough
00:10:00.300
job of explaining exactly how this is happening.
00:10:03.340
But, you know, we just had a new rollover with first-year doctors who start in July and
00:10:09.340
every one of them knows by the third day of work that the antibiotics that they used in
00:10:14.280
medical school are no longer working and they got to use a new crop of drugs just to treat
00:10:21.400
And that's because the bacteria are evolving, as you mentioned, and they're coming up with
00:10:26.960
these ingenious ways to destroy the antibiotics that we've relied upon for a generation.
00:10:31.700
One of the things they do is they make these things called efflux pumps, which are like
00:10:36.600
microscopic vacuum cleaners, and they suck up antibiotics and they spit them out.
00:10:41.700
And then they use these enzymes that can chop up antibiotics.
00:10:45.500
And so what we do and what my research is, is we look for new ways to fool the bacteria.
00:10:51.080
And so one thing we found, for example, is that bacteria love iron.
00:10:55.280
So we'll use a Trojan horse approach where we will attach an antibiotic to iron.
00:11:01.700
With the hope that the bacteria will see that iron and eat it and suck it up.
00:11:05.780
And along with it, the antibiotic will go inside the cell and kill it.
00:11:09.960
And we found that to be a pretty successful method so far for killing certain types of
00:11:15.280
And so, you know, the stuff that I do is, as I mentioned before, kind of scary stuff.
00:11:20.760
But I'm also really excited and optimistic about all of the amazing science that's going on where
00:11:26.640
we're constantly trying to fool the bacteria and come up with the way to save, you know,
00:11:34.540
It's extraordinary the kind of science that's being done.
00:11:37.640
And I don't think we're talking about it enough.
00:11:39.680
You know, much of the work that you see in the newspapers has to do with the outbreaks or
00:11:44.740
with the evolution of these drug-resistant bacteria.
00:11:48.400
But I'd like to see a bit more about the profiles of the scientists who are coming up with
00:11:53.600
Yeah, I mean, I can see the basis for hope, although we might be a little slow in getting
00:11:58.740
But, you know, it's the difference between not having a remedy and having one that actually
00:12:05.100
works and works as emphatically as a antibiotic that works does, in fact, work.
00:12:12.940
The 1950s must have been a mind-blowing decade to live through to suddenly see these appalling
00:12:22.380
Now we're talking about not just antibiotics, but, you know, let's add vaccines to that picture.
00:12:28.220
And then it just begins to look like every previous generation of humanity begins to look
00:12:34.160
just unfortunate for having been born at the wrong time.
00:12:37.720
Because now we have these cures for diseases that people can just forget about for the rest
00:12:44.020
And yet, the problem, as you point out in your book, is that we should have always known
00:12:57.980
And, of course, our treatment and, you know, in the worst case, our misuse of antibiotics is
00:13:05.340
creating a selection pressure which will select for resistance.
00:13:12.020
And, you know, I opened my book with a scene from the pre-antibiotic era, which is that
00:13:17.340
we're on a battlefield in France and there are these soldiers who are getting hit with
00:13:24.520
And what do you do before there are antibiotics?
00:13:27.360
Well, you can try antiseptic fluid, it didn't work all that well, or you can try a hacksaw.
00:13:35.720
And that, increasingly, is what people have to do, is just go to the hacksaw and cut somebody's
00:13:41.360
leg off to prevent them from getting an infection.
00:13:44.260
And the reason for that is that if the infection that's on the skin or on the leg gets into the
00:13:52.500
And if you have sepsis, you're going to die without antibiotics.
00:13:55.800
And so, you know, I wanted to paint that picture for people to recognize that we're heading
00:14:00.340
to a pre-antibiotic era where the drugs we've relied upon for 75 years don't work anymore.
00:14:06.620
And this is, you know, it's not a period to say, it's not a doomsday scenario.
00:14:12.060
We have a chance to invest in new treatments, but we have to do so selectively and carefully.
00:14:17.320
And this is really an inflection point for humanity where we can say, this is an important
00:14:23.340
It's like whatever else, you know, you hear about every day.
00:14:26.400
This needs to be talked about in the same breath as a danger that we can invest in and come
00:14:32.240
Let's talk about the problem of overuse, which is part of what got us here.
00:14:38.300
I mean, I guess, you know, we would have gotten here even if we'd used these drugs as circumspectly
00:14:44.380
as possible, but there is this pervasive problem of overuse.
00:14:49.120
And I'm wondering if the incentives are misaligned here between the individual and society, or
00:14:57.660
if there's just a new way of understanding this.
00:15:00.300
Because when I think about what most people's experience is in getting sick or, you know,
00:15:07.100
watching their kid get sick and then facing the question of, you know, whether to treat
00:15:12.700
with an antibiotic, it has been a very frequent experience for many of us to be prescribed
00:15:19.340
an antibiotic, essentially to be on the safe side.
00:15:23.960
You haven't even gotten to the point where an infection has been cultured and you know,
00:15:32.240
You're given a broad spectrum antibiotic and this is just the prudent thing to do.
00:15:37.440
And now we're stepping back and saying, well, this is not great for society because, again,
00:15:44.440
we're part of the arms race that is creating a selection environment for superbugs.
00:15:51.680
But is part of the problem here that what is in fact prudent for an individual is raising
00:16:00.780
the risk for society or are the risks actually the same?
00:16:05.260
I mean, that is when you're taking an antibiotic, as it said, just to be on the safe side, are
00:16:11.100
you actually running the risk of breeding a superbug that is likely to be a problem for you first?
00:16:16.780
Or is it conceivable that you're actually being prudent for yourself, but conceivably becoming
00:16:24.820
a problem for society and how you're using these drugs?
00:16:28.740
Well, I'm a medical school professor at Cornell and that question that you just asked is
00:16:35.100
what comes up on rounds almost every single day in various iterations, which is we've got
00:16:41.860
a patient in front of us who may have an infection and we're not sure, do we give them an antibiotic
00:16:49.400
And, you know, generations of young doctors and old doctors have been dealing with that
00:16:53.720
And I'll tell you, I was given a talk about superbugs a couple of weeks ago and there was
00:16:58.200
a guy who raised his hand and said, you know how locusts were cast upon the earth as a judgment
00:17:05.280
Do you think superbugs have been cast upon the earth as a similar judgment for human behavior?
00:17:10.280
And the question caught me off guard at first, but there's an argument to be made that in
00:17:15.240
the same way that we brought this on ourselves.
00:17:18.460
And the issue really is on the small scale and the large scale.
00:17:22.240
On the small scale, we've got doctors who are prescribing antibiotics, as you mentioned,
00:17:29.400
And that's no longer good enough as an excuse to prescribe something.
00:17:36.920
We have these people in the hospital who are called antibiotic stewards.
00:17:40.820
And if you want to prescribe an antibiotic, one of our powerful drugs, the steward has
00:17:50.800
And I'll tell you, it's a thankless job because what happens is a surgeon, you know, orders
00:17:55.760
an expensive antibiotic and then I have to call them and say, I'm sorry, that's the wrong
00:18:09.440
And so we're trying to check that the doctor's misprescribing things.
00:18:14.540
But also, this is about patients can do a better job as well.
00:18:17.700
You know, if your doctor prescribes five days of an antibiotic and you stop taking it after
00:18:22.080
day two because you're feeling better, that gives the bugs a chance to mutate and to evolve
00:18:30.220
And so it selects out the ones that can survive.
00:18:32.840
And so that's sort of on the small scale how we can be doing a better job.
00:18:37.020
Let me just ask you about the logic of that, Matt.
00:18:39.060
When the steward is saying, no, no, don't use that drug.
00:18:42.840
Is that a case where he or she is trying to preserve the efficacy of the last line defenses
00:18:53.720
And so what happens is, I'll give you an example.
00:18:55.620
There's an antibiotic called meropenem that we love using because it is so strong and it
00:19:02.260
And so if you're a doctor who just performed a complicated abdominal surgery, you want things
00:19:07.740
to go well for that patient, you're going to ask for meropenem.
00:19:11.180
And I'm going to say, well, based on everything we know about the patient and the environment
00:19:15.600
and the type of surgery you did, you could use ceftriaxone, which is not nearly as strong.
00:19:21.720
And then we have to have an argument about how to go forward.
00:19:25.840
And, you know, I was listening to your podcast with Ricky Gervais and he started out by telling
00:19:31.120
you that there's no place for nuanced arguments anymore.
00:19:34.720
And I felt so bad for him because all I do is have nuanced arguments with people all day
00:19:40.020
And I have many nuanced arguments about antibiotics with very sharp surgeons and clinicians who
00:19:49.580
And we have to be the ones as stewards to say that's not the right drug and face the
00:19:57.840
So there really is a misalignment between the interests of the patient, you know, narrowly
00:20:04.660
construed and the interests of society with respect to a choice about which drug to use.
00:20:11.440
And, you know, this is, I'm on the ethics committee and my research interests sort of are the
00:20:15.380
intersection of infectious diseases and medical ethics.
00:20:19.420
And what we talk about a lot and what I study is, what do you do if you're a doctor and you
00:20:24.820
have a patient who's got, let's say, two weeks to live, they've got terminal cancer and they
00:20:31.880
Do you treat them with one of the powerful antibiotics that we have, one of our precious drugs in the
00:20:36.860
arsenal and potentially breed resistance and potentially breed superbugs, but to save that
00:20:45.380
As I've found, doctors approach that question very differently and there's no uniform answer
00:20:53.280
And so sort of the next generation of clinicians are sort of winging it and figuring it out
00:20:59.200
on the fly, which is how do you make life and death decisions when there is no formal
00:21:05.980
And so that's sort of on the small scale question of antibiotics.
00:21:08.800
And then there's the larger scale issue, which is that we are using syphilis drugs and tuberculosis
00:21:16.600
We're using our powerful fungal drugs in tulip gardens.
00:21:20.420
We're pumping meat producing animals full of antibiotics.
00:21:24.420
And, you know, whenever people hear this, they say, well, that's terrible.
00:21:28.000
But the reason that it doesn't stop is that there are powerful lobbies behind big orange,
00:21:35.740
Big tulip is something that you have to contend with.
00:21:39.100
And these are things that allow, these groups allow the antibiotics to go in places they
00:21:45.640
And then when we search the soil around those tulips, it's full of superbugs.
00:21:50.620
And if you're somebody with a weakened immune system, you breathe in the wrong thing, you
00:21:56.260
And we're trying to become much more judicious about how we use those drugs.
00:22:01.080
So how are our oranges and our tulips getting syphilis?
00:22:05.900
Yeah, they're very promiscuous, oranges and tulips.
00:22:10.500
And we're trying to get, you know, starts with education, get them early.
00:22:14.620
But what we recognize that there have been just sort of this freewheeling approach to
00:22:22.380
And that brings up another issue, which is the more we look for superbugs, the more we
00:22:27.540
And people try to categorize what's the burden of disease or what's the burden of these things
00:22:33.400
We don't even know what's going on in Africa or in many places in sub-Saharan Africa, in
00:22:41.180
Every time we start looking for superbugs, we end up finding much more than we expected.
00:22:47.660
And I think that that's only going to continue to grow in the years ahead.
00:22:50.880
And so, you know, part of it is getting better diagnostics so that we can know what we're
00:22:56.000
dealing with so that we can come up with treatment plans.
00:22:59.180
As far as the source of each new antibiotic, what percentage of them come from nature?
00:23:06.280
I mean, penicillin, it was a compound produced by a fungus, right?
00:23:10.640
So how much of our drug development is a matter of finding happy accidents in nature and how
00:23:17.600
much is us synthesizing new drugs based on a first principle understanding of the target
00:23:25.200
Yeah, you hit on the two major approaches, which is, do we just get lucky and hope for
00:23:36.140
What we're finding is that it's getting to be prohibitively expensive to build new
00:23:40.600
antibiotics atom by atom or molecule by molecule.
00:23:44.480
So what people are doing now is they're searching in the soil.
00:23:48.200
And the reason for that is that, you know, beneath our feet, there is this subterranean
00:23:52.520
warfare where survival of the fittest bacteria and fungi are pumping out chemicals to kill
00:23:59.620
And if we can pull one of those out, you've got yourself an antibiotic.
00:24:04.140
The problem is that it typically costs about a billion dollars and 10 years of testing to
00:24:10.360
show that that chemical is safe and effective as an antibiotic.
00:24:14.580
And fewer and fewer companies want to take that financial risk because if they get that drug
00:24:20.800
approved, you know, compare it to a blood pressure medicine or a lipid lowering agent, these
00:24:30.000
The doctors are very stingy about prescribing them.
00:24:34.560
And then even that great new antibiotic is going to wear out its welcome.
00:24:40.800
We don't even want to go on the fishing expedition anymore.
00:24:44.140
And so that has kind of led us to what I consider the most important medical issue that no one
00:24:50.940
is talking about, which is that the antibiotic market is broken.
00:24:55.040
And we should be asking every politician, every political candidate, what are you going to do
00:24:59.860
If you'd like to continue listening to this conversation, you'll need to subscribe at
00:25:08.080
Once you do, you'll get access to all full length episodes of the Making Sense podcast,
00:25:12.360
along with other subscriber only content, including bonus episodes and AMAs and the
00:25:17.640
conversations I've been having on the Waking Up app.
00:25:20.240
The Making Sense podcast is ad free and relies entirely on listener support.